Inspiration Healthcare Group PLC Publication of Annual Report and Notice of AGM

RNS Number : 6460Y

Inspiration Healthcare Group PLC

31 July 2024

 

31 July 2024

 

Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Company" or the "Group")

 

Publication of Annual Report and Accounts for the year ended 31 January 2024

Notice of Annual General Meeting

 

 

Inspiration Healthcare Group plc (AIM: IHC), the global medical technology company pioneering specialist neonatal intensive care medical devices, announces that the Annual Report and Accounts for the year ended 31 January 2024 and the notice of its Annual General Meeting ("AGM") have been published on the Company's website at www.inspirationhealthcaregroup.com and will be posted to shareholders later today.

 

AGM and voting

The AGM of Inspiration Healthcare will be held at 11:00 am (UK time) on 17 September 2024 at Unit 7/8 Commerce Park, Commerce Way, Croydon, CR0 4YL.

 

Voting by proxy

Shareholders will not receive a hard copy form of proxy for the AGM in the post. Instead, shareholders will be able to appoint a proxy electronically using the link www.signalshares.com. Shareholders will need to log into their Signal Shares account or register if that shareholder has not previously done so. To register, shareholders will need their Investor Code, this is detailed on the share certificate or available from our Registrars, Link Group. Proxy votes must be received by no later than 11.00 am on 13 September 2024. Alternatively, shareholders may submit their proxy vote via CREST where applicable.

 

Request a hard copy form of proxy

Shareholders may request a hard copy form of proxy directly from the Registrars, Link Group on 0371 664 0300. Calls are charged at the standard geographic rate and will vary by provider. Calls outside the United Kingdom will be charged at the applicable international rate. Lines are open between 09:00 - 17:30, Monday to Friday excluding public holidays in England and Wales. Alternatively, shareholders can request a hard copy proxy card by emailing [e-mail].

 

Enquiries:

 

For more information contact:
Inspiration Healthcare Group plc	Tel: [phone]
Roy Davis, Executive Chairman and Interim CEO
Alan Olby, Chief Financial Officer
Panmure Liberum Capital Limited (Nomad and Broker)	Tel: [phone]
Richard Lindley, Will King, Joshua Borlant
Walbrook PR Ltd	Tel: [phone] or [e-mail]
Anna Dunphy Stephanie Cuthbert Louis Ashe-Jepson	Mob: [phone] Mob: [phone] Mob: [phone]

 

About Inspiration Healthcare Group plc

 

Inspiration Healthcare (AIM: IHC) designs, manufactures and markets pioneering medical technology. Based in the UK, the Company specialises in neonatal intensive care medical devices, which are addressing a critical need to help to save the lives and improve the outcomes of patients, starting with the very first breaths of life.

 

The Company has a broad portfolio of its own products and complementary distributed products, for use in neonatal intensive care designed to support even the most premature babies throughout their hospital stay. Its own branded products range from highly sophisticated capital equipment such as ventilators for life support through to single-use disposables.

 

The Company sells its products directly to hospitals and healthcare providers in the UK and Ireland, where it also distributes a range of advanced medical technologies for infusion therapy.  In the rest of the world the Company has an established network of distribution partners around the world giving access to more than 75 countries.

 

The Company operates in the UK from its world-class Manufacturing and Technology Centre in Croydon, South London and in the USA from its facility in Melbourne, Florida.

 

Further information on Inspiration Healthcare can be found at www.inspirationhealthcaregroup.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

NOAFLFFSDTILVIS